Under the terms of the deal, the company will gain the exclusive global license to develop, manufacture and commercialise Chinese drugmaker Hansoh Pharmaceutical Groups HS-10535, an experimental oral drug that targets the receptors for GLP-1, Merck said on Wednesday (Dec 18)
Exendin-4 demonstrated the ability to bind to the same receptors as human GLP-1, producing similar glucose-lowering effects, but with a significantly longer duration of action
Klinic does not prescribe Ozempic because it is indicated for type 2 diabetes, which requires in-person lab monitoring, A1C testing, and ongoing glucose management that cannot be fully conducted through telehealth
Alcohol, acting like an unruly guest, disrupts this harmonious choreography, leading to consequences that extend beyond immediate digestive discomfort